Cyblex MV 40.2 mg Tablet (15 Tab)

About Cyblex MV 40.2 mg Tablet:

Each uncoated Cyblex MV 40.2 mg tablet contains Metformin Hydrochloride 500 mg, Gliclazide 40 mg, Voglibose 0.2 mg and Excipients q.s.

Voglibose is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with type 2 diabetes mellitus.

Gliclazide belongs to the sulfonylurea class of insulin secretagogues that increases insulin sensitivity at peripheral target sites by stimulating insulin release from the pancreatic ß-cells. It also reduces insulin uptake & glucose output of the liver.

Metformin is a biguanide antihyperglycaemic agent which improves glucose tolerance by lowering both basal and postprandial plasma glucose. It decreases hepatic glucose production, delays intestinal glucose absorption, and improves insulin sensitivity by enhancing peripheral glucose uptake and utilization.

Use of Cyblex MV 40.2 mg Tablet:

Cyblex MV 40.2 mg tablet is prescribed for the treatment of patients with type 2 diabetes mellitus. It helps control high blood glucose levels.

Usage Direction of Cyblex MV 40.2 mg Tablet:

• Cyblex MV 40.2 mg tablet is intended for oral use only in a dose and direction as advised by the physician.
• Cyblex MV 40.2 mg tablet is taken whole with the help of water.
• Do not crush, chew, or break the tablet.
• Do not skip or stop the medicine without physician's advice.
• Do not consume more than the prescribed quantity.

Precaution & Related information of Cyblex MV 40.2 mg Tablet:

• It is dangerous to take this preparation except under medical supervision.
• If allergic to this medicine inform the physician immediately.
• If find any other complication inform the physician immediately.
• Consult with the physician during pregnancy & lactation.
• Keep out of reach of children.

Storage condition of Cyblex MV 40.2 mg Tablet:

Store between 10ºC to 25ºC, at dry & dark place.